Research and Markets (http://www.researchandmarkets.com/research/9rtv5q/smoking) has announced the addition of the "Smoking Cessation-Pipeline Insights, 2015" subscription to their offering.

This Smoking Cessation-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Smoking Cessation.

This report provides information on the therapeutic development based on the Smoking Cessation dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Smoking Cessation Overview
  2. Smoking Cessation Pipeline Therapeutics
  3. Smoking Cessation Therapeutics under Development by Companies
  4. Smoking Cessation Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Smoking Cessation Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Smoking Cessation Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Smoking Cessation Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Smoking Cessation - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Smoking Cessation - Discontinued Products
  19. Smoking Cessation - Dormant Products
  20. Companies Involved in Therapeutics Development for Smoking Cessation
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/9rtv5q/smoking